WO2003064589A3 - Therapeutic polypeptides, nucleic acids encoding same, and methods of use - Google Patents

Therapeutic polypeptides, nucleic acids encoding same, and methods of use Download PDF

Info

Publication number
WO2003064589A3
WO2003064589A3 PCT/US2002/024483 US0224483W WO03064589A3 WO 2003064589 A3 WO2003064589 A3 WO 2003064589A3 US 0224483 W US0224483 W US 0224483W WO 03064589 A3 WO03064589 A3 WO 03064589A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
nucleic acids
polypeptides
polypeptide
acids encoding
Prior art date
Application number
PCT/US2002/024483
Other languages
French (fr)
Other versions
WO2003064589A2 (en
Inventor
Ramesh Kekuda
Charles E Miller
Meera Patturajan
Carol E A Pena
Daniel K Rieger
Richard A Shimkets
Bryan D Zerhusen
Li Li
Weizhen Ji
Original Assignee
Curagen Corp
Ramesh Kekuda
Charles E Miller
Meera Patturajan
Carol E A Pena
Daniel K Rieger
Richard A Shimkets
Bryan D Zerhusen
Li Li
Weizhen Ji
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/210,172 external-priority patent/US20040043928A1/en
Application filed by Curagen Corp, Ramesh Kekuda, Charles E Miller, Meera Patturajan, Carol E A Pena, Daniel K Rieger, Richard A Shimkets, Bryan D Zerhusen, Li Li, Weizhen Ji filed Critical Curagen Corp
Priority to AU2002365216A priority Critical patent/AU2002365216A1/en
Publication of WO2003064589A2 publication Critical patent/WO2003064589A2/en
Publication of WO2003064589A3 publication Critical patent/WO2003064589A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
PCT/US2002/024483 2001-01-23 2002-08-02 Therapeutic polypeptides, nucleic acids encoding same, and methods of use WO2003064589A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002365216A AU2002365216A1 (en) 2001-01-23 2002-08-02 Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Applications Claiming Priority (53)

Application Number Priority Date Filing Date Title
US26360401P 2001-01-23 2001-01-23
US30950101P 2001-08-02 2001-08-02
US60/309,501 2001-08-02
US31029101P 2001-08-03 2001-08-03
US60/310,291 2001-08-03
US31054401P 2001-08-07 2001-08-07
US60/310,544 2001-08-07
US31095101P 2001-08-08 2001-08-08
US60/310,951 2001-08-08
US31129201P 2001-08-09 2001-08-09
US60/311,292 2001-08-09
US31197901P 2001-08-13 2001-08-13
US60/311,979 2001-08-13
US31289201P 2001-08-16 2001-08-16
US60/312,892 2001-08-16
US31320101P 2001-08-17 2001-08-17
US31341501P 2001-08-17 2001-08-17
US60/313,201 2001-08-17
US60/313,415 2001-08-17
US31370201P 2001-08-20 2001-08-20
US31364301P 2001-08-20 2001-08-20
US60/313,702 2001-08-20
US60/313,643 2001-08-20
US31403101P 2001-08-21 2001-08-21
US60/314,031 2001-08-21
US31446601P 2001-08-23 2001-08-23
US60/314,466 2001-08-23
US31540301P 2001-08-28 2001-08-28
US60/315,403 2001-08-28
US31585301P 2001-08-29 2001-08-29
US60/315,853 2001-08-29
US32271601P 2001-09-17 2001-09-17
US60/322,716 2001-09-17
US32399401P 2001-09-21 2001-09-21
US60/323,994 2001-09-21
US34023301P 2001-12-14 2001-12-14
US60/340,233 2001-12-14
US35459102P 2002-02-05 2002-02-05
US60/354,591 2002-02-05
US36547802P 2002-03-19 2002-03-19
US60/365,478 2002-03-19
US37398902P 2002-04-19 2002-04-19
US37381402P 2002-04-19 2002-04-19
US37382502P 2002-04-19 2002-04-19
US60/373,814 2002-04-19
US60/373,825 2002-04-19
US60/373,989 2002-04-19
US37463202P 2002-04-23 2002-04-23
US60/374,632 2002-04-23
US38697102P 2002-06-07 2002-06-07
US60/386,971 2002-06-07
US10/210,172 2002-08-01
US10/210,172 US20040043928A1 (en) 2001-08-02 2002-08-01 Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Publications (2)

Publication Number Publication Date
WO2003064589A2 WO2003064589A2 (en) 2003-08-07
WO2003064589A3 true WO2003064589A3 (en) 2005-08-04

Family

ID=27671413

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/024483 WO2003064589A2 (en) 2001-01-23 2002-08-02 Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Country Status (2)

Country Link
AU (1) AU2002365216A1 (en)
WO (1) WO2003064589A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
RU2592672C9 (en) 2010-12-08 2016-11-27 СтемСентРкс, Инк. Novel modulators and methods for use thereof
US9381205B2 (en) 2013-11-04 2016-07-05 Pfizer, Inc. Anti-EFNA4 antibody-drug conjugates

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012823A2 (en) * 1999-05-28 2001-02-22 University Of Iowa Research Foundation Macular degeneration diagnostics and therapeutics

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012823A2 (en) * 1999-05-28 2001-02-22 University Of Iowa Research Foundation Macular degeneration diagnostics and therapeutics

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE UNIPROT TREMBL. [online] 1 December 2001 (2001-12-01), XP002288678, Database accession no. AK056571 *
ZHANG ET AL.: "Structure and expression of fibrilin-2, a novel microfibrillar component preferentially located in elastic matrices.", THE JOURNAL OF CELL BIOLOGY., vol. 124, no. 5, 1994, pages 855 - 863, XP002982700 *

Also Published As

Publication number Publication date
WO2003064589A2 (en) 2003-08-07
AU2002365216A1 (en) 2003-09-02
AU2002365216A8 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
WO2004000997A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003057158A3 (en) Method of treating apoptosis and compositions thereof
WO2003080856A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002055705A3 (en) Proteins and nucleic acids encoding same
WO2002068649A3 (en) Proteins and nucleic acids encoding same
WO2002081518A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002098917A3 (en) Human proteins and nucleic acids encoding same
WO2002029058A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2001090155A3 (en) Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
WO2001029217A3 (en) Novel polypeptides and polynucleotides encoding same
WO2002068652A3 (en) Nov-x proteins and nucleic acids encoding same
WO2002055704A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2003029423A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002081510A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002055702A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2003031571A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2002066643A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2003022998A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003078572A3 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
WO2003040329A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003085124A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002057452A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2002068647A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2001025436A3 (en) Endozepine-like polypeptides and polynucleotides encoding same
WO2003064589A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP